ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionCrossmark Global Holdings, Inc.
Latest Disclosed Ownership25,826 shares
Latest Disclosed Value $ 5,797,420
Crossmark Global Holdings, Inc. reports 6.57% decrease in ownership of RMD / ResMed Inc.

On May 11, 2026 - Crossmark Global Holdings, Inc. filed a 13F-HR form disclosing ownership of 25,826 shares of ResMed Inc. (MX:RMD) valued at $5,797,420 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 27,642 shares of ResMed Inc.. This represents a change in shares of -6.57% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F RESMED COM 761152107 25,826 -1,816 -6.57 5,797 -12.93 0.0847
2026-02-03 2025-12-31 13F RESMED COM 761152107 27,642 -2,666 -8.80 6,658 -19.74 0.0950
2025-11-12 2025-09-30 13F RESMED COM 761152107 30,308 17,487 136.39 8,296 150.86 0.1243
2025-08-08 2025-06-30 13F RESMED COM 761152107 12,821 1,862 16.99 3,308 34.81 0.0534
2025-04-30 2025-03-31 13F RESMED COM 761152107 10,959 4,116 60.15 2,453 245,200.00 0.0433
2025-01-16 2024-12-31 13F RESMED COM 761152107 6,843 -891 -11.52 2 0.00 0.0285
2024-11-04 2024-09-30 13F RESMED COM 761152107 7,734 -499 -6.06 2 0.00 0.0337
2024-07-29 2024-06-30 13F RESMED COM 761152107 8,233 -228 -2.69 2 0.00 0.0301
2024-05-13 2024-03-31 13F RESMED COM 761152107 8,461 -84 -0.98 2 0.00 0.0321
2024-02-13 2023-12-31 13F RESMED COM 761152107 8,545 -538 -5.92 1 0.00 0.0305
2023-11-08 2023-09-30 13F RESMED COM 761152107 9,083 -1,114 -10.92 1 -50.00 0.0310
2023-07-31 2023-06-30 13F RESMED COM 761152107 10,197 323 3.27 2 0.00 0.0489
2023-05-12 2023-03-31 13F RESMED COM 761152107 9,874 -391 -3.81 2 0.00 0.0509
2023-01-19 2022-12-31 13F RESMED COM 761152107 10,265 1,500 17.11 2 -99.90 0.0532
2022-11-01 2022-09-30 13F RESMED COM 761152107 8,765 -63 -0.71 1,913 3.41 0.0531
2022-07-29 2022-06-30 13F RESMED COM 761152107 8,828 160 1.85 1,850 -11.99 0.0479
2022-05-11 2022-03-31 13F RESMED COM 761152107 8,668 350 4.21 2,102 -3.00 0.0469
2022-01-10 2021-12-31 13F RESMED COM 761152107 8,318 -4,690 -36.05 2,167 -36.79 0.0471
2021-10-21 2021-09-30 13F/A-1 RESMED COM 761152107 13,008 -650 -4.76 3,428 1.81 0.0803
2021-10-13 2021-09-30 13F RESMED COM 761152107 7,810 -5,848 316 0.0362
2021-07-21 2021-06-30 13F RESMED COM 761152107 13,658 -1,040 -7.08 3,367 18.06 0.0792
2021-04-15 2021-03-31 13F RESMED COM 761152107 14,698 -1,130 -7.14 2,852 -15.22 0.0706
2021-01-14 2020-12-31 13F RESMED COM 761152107 15,828 3,041 23.78 3,364 53.47 0.0851
2020-10-08 2020-09-30 13F RESMED COM 761152107 12,787 -1,054 -7.62 2,192 -17.50 0.0615
2020-08-14 2020-06-30 13F RESMED COM 761152107 13,841 -621 -4.29 2,657 24.74 0.0775
2020-04-28 2020-03-31 13F RESMED COM 761152107 14,462 -80 -0.55 2,130 -5.50 0.0762
2020-02-06 2019-12-31 13F RESMED COM 761152107 14,542 2,258 18.38 2,254 35.78 0.0619
2019-10-09 2019-09-30 13F RESMED COM 761152107 12,284 -93,605 -88.40 1,660 -87.15 0.0485
2019-07-09 2019-06-30 13F RESMED COM 761152107 105,889 -1,827 -1.70 12,922 15.39 0.3623
2019-05-02 2019-03-31 13F RESMED COM 761152107 107,716 332 0.31 11,199 -8.42 0.3179
2019-01-31 2018-12-31 13F RESMED COM 761152107 107,384 -7,058 -6.17 12,228 -7.36 0.3790
2018-11-08 2018-09-30 13F/A-1 RESMED COM 761152107 114,442 3,142 2.82 13,200 14.50 0.3350
2018-11-06 2018-09-30 13F RESMED COM 761152107 111,300 0 11,528
2018-07-31 2018-06-30 13F RESMED COM 761152107 111,300 4,207 3.93 11,528 9.32 0.3092
2018-04-16 2018-03-31 13F RESMED COM 761152107 107,093 -789 -0.73 10,545 15.41 0.2726
2018-02-05 2017-12-31 13F RESMED COM 761152107 107,882 8,939 9.03 9,137 19.99 0.2196
2017-10-27 2017-09-30 13F RESMED COM 761152107 98,943 0 0.00 7,615 0.00 0.1963
2017-10-25 2016-09-30 13F RESMED COM 761152107 98,943 98,943 7,615 0.1963
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.